Dr. Harsh Singh
doctor
Dr. Harsh Singh is affiliated with Mass General Brigham Cancer Institute, where he has acknowledged the clinical trial results of daraxonrasib as a groundbreaking advancement in the treatment of pancreatic cancer.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Israel:
Dr. Harsh Singh from Mass General Brigham called the findings a landmark study in pancreatic cancer treatment.
8
Debby Orcutt
Ron Orcutt
Dr Samik Rouchudhury
Dr Rachna Saraf
Dr Brian Wolpin
Professor Ze Ev Weinberg
Dr Julie Gralow
Mark Goldsmith
ידיעות אחרונות (Yedioth Ahronoth / ynet): "לא רואים דברים כאלה": הקהל הריע לתרופה הזו